| Microarray-based gene expression profiling for molecular classification of breast cancer and identification of new targets for therapy R Sandhu, JS Parker, WD Jones, CA Livasy, WB Coleman Laboratory Medicine 41 (6), 364-372, 2010 | 93 | 2010 |
| Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer R Sandhu, AG Rivenbark, RM Mackler, CA Livasy, WB Coleman International journal of oncology 44 (2), 563-572, 2013 | 92 | 2013 |
| Tumor intrinsic subtype is reflected in cancer-adjacent tissue P Casbas-Hernandez, X Sun, E Roman-Perez, M D'Arcy, R Sandhu, ... Cancer Epidemiology, Biomarkers & Prevention 24 (2), 406-414, 2015 | 88 | 2015 |
| Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation JD Roll, AG Rivenbark, R Sandhu, JS Parker, WD Jones, LA Carey, ... Experimental and molecular pathology 95 (3), 276-287, 2013 | 77 | 2013 |
| Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines R Sandhu, AG Rivenbark, WB Coleman International journal of oncology 41 (2), 721-732, 2012 | 75 | 2012 |
| Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer X Sun, GL Gierach, R Sandhu, T Williams, BR Midkiff, J Lissowska, ... Clinical Cancer Research 19 (18), 4972-4982, 2013 | 66 | 2013 |
| Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b R Sandhu, AG Rivenbark, WB Coleman Breast cancer research and treatment 131, 385-399, 2012 | 62 | 2012 |
| Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status R Sandhu, J Rein, M D’Arcy, JI Herschkowitz, KA Hoadley, MA Troester Carcinogenesis 35 (11), 2567-2575, 2014 | 56 | 2014 |
| Imaging extracellular matrix remodeling in vitro by diffusion-sensitive optical coherence tomography RL Blackmon, R Sandhu, BS Chapman, P Casbas-Hernandez, JB Tracy, ... Biophysical journal 110 (8), 1858-1868, 2016 | 49 | 2016 |
| DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas MA Troester, KA Hoadley, M D’arcy, AD Cherniack, C Stewart, ... NPJ breast cancer 2 (1), 1-7, 2016 | 42 | 2016 |
| The radiation response of V79 and human tumour multicellular spheroids–cell survival and growth delay studies CM West, RR Sandhu, IJ Stratford British journal of cancer 50 (2), 143-151, 1984 | 37 | 1984 |
| Body mass index associated with genome-wide methylation in breast tissue BY Hair, Z Xu, EL Kirk, S Harlid, R Sandhu, WR Robinson, MC Wu, ... Breast cancer research and treatment 151, 453-463, 2015 | 35 | 2015 |
| Benign breast tissue composition in breast cancer patients: association with risk factors, clinical variables, and gene expression X Sun, R Sandhu, JD Figueroa, GL Gierach, ME Sherman, MA Troester Cancer Epidemiology, Biomarkers & Prevention 23 (12), 2810-2818, 2014 | 33 | 2014 |
| Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stroma R Sandhu, L Chollet-Hinton, EL Kirk, B Midkiff, MA Troester Human pathology 48, 60-68, 2016 | 25 | 2016 |
| Dysregulation of the epigenome in human breast cancer: contributions of gene-specific DNA hypermethylation to breast cancer pathobiology and targeting the breast cancer … R Sandhu, JD Roll, AG Rivenbark, WB Coleman The American journal of pathology 185 (2), 282-292, 2015 | 25 | 2015 |
| Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast L Chollet-Hinton, S Puvanesarajah, R Sandhu, EL Kirk, BR Midkiff, ... Modern Pathology 31 (7), 1085-1096, 2018 | 12 | 2018 |
| Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue X Sun, DA Stewart, R Sandhu, EL Kirk, WW Pathmasiri, SL McRitchie, ... Plos one 13 (4), e0193792, 2018 | 6 | 2018 |
| Differential Responses to Hormone Therapy Among ER+/PR+/HER2‐Breast Cancers That Differentially Express the Estrogen Response Signature R Sandhu, J Parker, C Anders, W Coleman The FASEB Journal 29, 284.7, 2015 | 1 | 2015 |
| Therapeutic Benefit of Chemotherapy and Hormone Therapy Among Estrogen Response Signature‐Positive ER+/PR+/HER2‐Breast Cancers R Sandhu, J Parker, C Anders, W Coleman The FASEB Journal 29, 926.6, 2015 | 1 | 2015 |
| Recurrence‐free Survival Among Patients With ER+/PR+/HER2‐Breast Cancers is Predicted by Expression of the Estrogen Response Signature R Sandhu, J Parker, C Anders, W Coleman The FASEB Journal 29, 926.2, 2015 | 1 | 2015 |
